DNMT3A and IDH1-R132 are frequently mutated in AML patients in Egypt whereas TET2 overexpression is not a frequent finding (Hamed et al., 2015; Salem et al., 2017; El Gammal et al., 2019). This evidence concerns the gene DNMT3A and acute myeloid leukemia.